Shingles (Herpes Zoster) Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

NHSE confirms changes to shingles and HPV vaccination programmes
Almost a million more people in England are now eligible for a shingles vaccination as part of an expansion which aims to protect more people at an earlier age. Also from this month, under 25s will now only need one dose of the HPV vaccine, instead of two. The updates from NHS England (NHSE), released... Read moreThe post NHSE confirms changes to shingles and HPV vaccination programmes appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - September 4, 2023 Category: Nursing Authors: Megan Ford Tags: Clinical Latest news Vaccinations Vaccinations and infections Source Type: news

Routine Vaccines Can Cut Risk for Later Alzheimer Disease
WEDNESDAY, Aug. 23, 2023 -- Prior vaccinations against tetanus and diphtheria, shingles, and pneumococcus are all associated with a reduced risk for developing Alzheimer disease, according to a study published online Aug. 7 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 23, 2023 Category: Pharmaceuticals Source Type: news

Vaccines Against Shingles, Pneumonia May Also Lower Your Alzheimer's Risk
MONDAY, Aug. 21, 2023 -- Certain adult vaccines, including shingles and pneumonia shots, may also help seniors fight off Alzheimer ' s disease, new research reveals. Prior vaccination with the shingles vaccine, pneumococcus vaccine or the tetanus and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 21, 2023 Category: General Medicine Source Type: news

GSK chief says RSV vaccine will start off slower than shingles shot
GlaxoSmithKline CEO Emma Walmsley on Wednesday said she expects uptake for the company's new RSV vaccine to start off slower than it did for its blockbuster shingles shot. But she is confident that the new vaccine will drive future sales. "I think the uptake on this we need to watch for through…#emmawalmsley #rsv #gsk #shingrix (Source: Reuters: Health)
Source: Reuters: Health - July 26, 2023 Category: Consumer Health News Source Type: news

Jab for killer virus found in 90% of Britons will soon be available to more people on NHS
Nearly one million more people in England will be eligible for a vaccine against shingles on the NHS from September. (Source: Daily Express - Health)
Source: Daily Express - Health - July 12, 2023 Category: Consumer Health News Source Type: news

Shingles vaccine extended to vulnerable over-50s
From September, nearly a million more people in England can be protected against the painful virus. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 11, 2023 Category: Consumer Health News Source Type: news

GP practices to offer shingles jab to 1m more people from September
GP practices will need to offer shingles vaccination to patients aged over 50 who are severely immunosuppressed and those turning 65 from 1 September, NHS England has confirmed. (Source: GP Online News)
Source: GP Online News - July 11, 2023 Category: Primary Care Tags: Clinical News Source Type: news

Eligibility extended for shingles vaccination in England
The shingles vaccination programme in England is changing from September, both on type of vaccine and who is eligible, with priority for over-50s who are immunocompromised. A letter to GPs, local medical committees and NHS leaders said the programme will be moving to two doses of non-live shingles vaccine Shingrix instead of the one-dose Zostavax... Read moreThe post Eligibility extended for shingles vaccination in England appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - July 6, 2023 Category: Nursing Authors: Wiliam Hunter Tags: Latest news Vaccinations and infections Source Type: news

Lower Dementia Risk May Be Linked With Shingles Vaccine
(MedPage Today) -- The shingles vaccine may be linked with a 20% lower dementia risk, an analysis of 300,000 health records suggested. Receiving the herpes zoster vaccine (Zostavax) reduced the probability of a new dementia diagnosis over 7 years... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - June 12, 2023 Category: Psychiatry Source Type: news

GSK rolls out its Shingles vaccine in India
The adult vaccine recommended for people aged 50 years and above, provides protection against shingles - a disease associated with debilitating pain and rashes caused by the reactivation of the varicella zoster virus (VZV). VZV is the same virus that causes chickenpox. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 24, 2023 Category: Pharmaceuticals Source Type: news

New STELARA ® (ustekinumab) Long-Term Data Support its Established Safety Profile in Inflammatory Bowel Disease and Durable Efficacy in Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, March 4, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced final pooled long-term safety results for STELARA® (ustekinumab) through five years in adults with moderately to severely active Crohn’s disease (CD) and four years in adults with moderately to severely active ulcerative colitis (UC), as well as final four-year clinical and endoscopic outcomes from the UNIFI long-term extension (LTE) study evaluating the efficacy of STELARA for the treatment of adults with moderately to severely active UC.1,2 These data are a part of Janssen’s 22 oral and poster ...
Source: Johnson and Johnson - March 4, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

FDA Panel Backs GSK ’s RSV Vaccine for Older People
GSK Plc’s vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV. The panel of 12 outside advisers to the Food and Drug Administration voted unanimously on Wednesday that GSK’s data show the Arexvy vaccine is effective. The same committee voted 10-2 that company data show the shot is safe. By contrast, it had voted 7-4 with one abstention to recommend Pfizer’s vaccine as both safe and effective in preventing RSV. [time-brightcove not-tgx=&...
Source: TIME: Health - March 2, 2023 Category: Consumer Health News Authors: Lisa Pham and Tanaz Meghjani/Bloomberg Tags: Uncategorized bloomberg wire Drugs healthscienceclimate News Source Type: news

GSK bullish on 2023 as earnings surpass expectations
UK drugmaker’s shingles vaccine boosts sales while demand for Covid-related products falls (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - February 1, 2023 Category: Pharmaceuticals Source Type: news

Free Shingles Vaccine, Negotiable Prescription Prices & Other Medicare Changes in 2023
The year 2023 brings changes to the rules, limits and options on all kinds of federal programs and Medicare is no exception. Roughly 65 million senior citizens who rely on Medicare for health coverage will pay less for several things, but more for Part A coverage. They will also get free…#cms #socialsecurity #shingrix #medicareparts #medicare #smartassetblog (Source: Reuters: Health)
Source: Reuters: Health - January 15, 2023 Category: Consumer Health News Source Type: news

Are you up to date on your vaccines?
Flu, measles, shingles — you want to prevent all of them. Yale clinical experts tell you how to stay up to date on your vaccinations. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 13, 2022 Category: Universities & Medical Training Source Type: news